Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 28, 2012; 18(28): 3635-3661
Published online Jul 28, 2012. doi: 10.3748/wjg.v18.i28.3635
Published online Jul 28, 2012. doi: 10.3748/wjg.v18.i28.3635
Table 1 Extracellular matrix molecules involved in wound repair and fibrosis
| Collagens | Fibrillar type collagens I-III-V |
| Non-fibrillar collagen type IV | |
| Glycoproteins | Laminin |
| Entactin/nidogen | |
| Fibronectin | |
| Tenascin | |
| Sparc/BM40 | |
| Thrombospondin | |
| Proteoglycans | Glycosaminoglycans (hyaluronic acid) |
| Heparan sulfate | |
| Chondroitin sulfate | |
| Perlecan | |
| ECM-modifying proteins | Matrix metalloproteinases |
| Tissue inhibitor of metalloproteinases |
Table 2 Cell types involved in intestinal fibrosis
| Cell type | Positive markers |
| Fibroblasts | Vimentin, FSP-1, N-cadherin (high), collagen type I, prolyl 4-hydroxylase |
| Intestinal subepithelial myofibroblasts | Vimentin, α-SMA, cadherin-11, FSP-1, collagen type I |
| Interstitial cells of Cajal | Vimentin, c-Kit receptor |
| Smooth muscle cells | Vimentin (low), α-SMA, Desmin, collagen type I |
| Stellate cells | Vitamin A, GFAP, α-SMA |
| Pericytes | a-SMA, desmin (low), MCSP, |
| RGS5, PDGFR-β | |
| CD80, CD86, CD 13, CD90 | |
| ANG I and II, ET-1, collagen type I | |
| Epithelial cells | E-cadherin, cytokeratins |
| Endothelial cells | CD31, vWF, VE-cadherin, N-cadherin (low), vimentin (low) |
| Bone marrow stem cells | |
| Hematopoietic stem cells | CD45, CD34, CD14 |
| Mesenchymal stem cells | CD105, CD73, CD44, CD71, CD90 |
| Fibrocytes | CD45, CD34, CD11, CD13, CD14, |
| CD80, CD86, collagen type I, α-SMA |
Table 3 Predominant pro-fibrotic cytokines
| Cytokines | Role in fibrosis | Ref. |
| IL-1/IL-33 | Activate myofibroblasts | [144,146] |
| Stimulate TGF expression | [145] | |
| Regulate chemokines, cytokines and MMPs secretion | [144] | |
| IL-4/IL-13 | Activate myofibroblasts | [147] |
| Increase deposition of collagen I, III and IV | [148] | |
| Induce production of latent TGF-β and activate TGF-β | [152,153] | |
| Promote fibrocyte differentiation | [154] | |
| IL-6 | Stimulates proliferation of fibroblasts | [157] |
| Modulates TGF-β and TGF-βRII | [156] | |
| Its neutralization improves fibrosis | [155] | |
| IL-21/IL-22 | Stimulate the expression of IL-4, IL-13 and IL-17 | [159] |
| Increase secretion of ECM degrading enzymes | [160] | |
| Maintain the integrity of the epithelial barrier | [161] | |
| Inhibit deposition of collagen | [163] | |
| IL-17/IL-23 | Maintain chronic inflammation in the gut | [143] |
| Induce activation and proliferation of myofibroblasts | [165] | |
| Stimulate deposition of collagen | [164] | |
| TNFα | Stimulates intestinal myofibroblast proliferation | [170] |
| Stimulates deposition of collagen | [171] | |
| Inhibits collagen degradation through TIMP-1 induction | [172,173] |
- Citation: Speca S, Giusti I, Rieder F, Latella G. Cellular and molecular mechanisms of intestinal fibrosis. World J Gastroenterol 2012; 18(28): 3635-3661
- URL: https://www.wjgnet.com/1007-9327/full/v18/i28/3635.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i28.3635
